Skip to content
Application 071891
- Type
- ANDA
- Sponsor
- WATSON LABS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SULINDAC | SULINDAC | TABLET;ORAL | 150MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0591-5661 | Sulindac | Sulindac | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5661 | Sulindac | Sulindac | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5661 | Sulindac | Sulindac | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5661 | Sulindac | Sulindac | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5661 | Sulindac | Sulindac | Actavis Pharma, Inc. | ANDA | Current |